- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
Recombinant TNFSF15 antibody is a specialized reagent for detecting tumor necrosis factor superfamily member 15, also known as vascular endothelial growth inhibitor or VEGI. TNFSF15 is primarily produced by endothelial cells and functions as a regulator of angiogenesis and immune responses. By inhibiting endothelial cell proliferation and promoting apoptosis, it acts as a natural suppressor of vascular growth. Because of these functions, TNFSF15 is studied in vascular biology, oncology, and inflammation research.
TNFSF15 belongs to the tumor necrosis factor superfamily and signals through receptors such as death receptor 3. Its activity influences both vascular development and immune regulation, where it promotes T cell activation and modulates cytokine production. Dysregulated TNFSF15 signaling has been linked to autoimmune conditions and altered tumor vasculature. Its ability to integrate vascular and immune responses highlights its broad significance.
The Recombinant TNFSF15 antibody clone VEGI/2052R provides accurate and reproducible recognition of this cytokine. Recombinant production ensures batch to batch consistency and minimizes variability. Clone VEGI/2052R has been applied to studies of endothelial biology, angiogenesis inhibition, and immune modulation. Its specificity makes it a dependable tool for both fundamental research and translational studies.
Research using clone VEGI/2052R has clarified how TNFSF15 suppresses tumor angiogenesis and enhances immune activity. Reduced expression has been associated with cancer progression, while altered signaling has been implicated in chronic inflammation and autoimmune disease. This antibody continues to advance understanding of how vascular and immune systems intersect.
NSJ Bioreagents supplies this Recombinant TNFSF15 antibody to support research in vascular biology, cancer, and immunology. The protein is also known as VEGI antibody, vascular endothelial growth inhibitor antibody, tumor necrosis factor ligand superfamily member 15 antibody, and death receptor 3 ligand antibody, reflecting the alternate terms found in research.
Titration of the recombinant TNFSF15 antibody may be required for optimal performance.
1. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.
A full length human recombinant protein was used as the immunogen for this recombinant TNFSF15 antibody.
Store the recombinant TNFSF15 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.